Long before the Corona vaccination, Pfizer was seen for its questionable ethics and profit-oriented actions without regard to harm. Vaccination-critical program “Imfgehisper” raised the scandal of the experimental antibiotic Trovan in a multi-part series about the pharmaceutical giant: As part of a study, this preparation was given to Nigerian children without the consent of their parents Was – Several young test subjects died.
You can find the first part of the Pfizer series on vaccination whispers here: The lure of profit and hidden side effects: Big Pharma has always acted only in its own interests
Guest commentary via #VaccinationWhispers. Listen to the current episode here or read the written version below:
Do you trust PFIZER? A Three-Party – Part 2 of 3
Scams: Origin and Impact
In Season 4 Episode #1 of #VACCINE FLUSTER we looked at the history and early irregularities of Pfizer. The media portrayal completely ignores the dark side of this pharmaceutical company.
As a result of its corrupt practices, Pfizer was accused of a variety of illegal acts. These range from price fixing, low product safety, bribery, advertising and marketing scams to environmental and human rights violations.
Pfizer pleaded guilty in 1999 breach of trust Found guilty and agreed to pay a total fine of $20 million. In these antitrust violations, Pfizer was accused of “participating in a conspiracy to raise and fix prices, allocate market share in the United States for a food preservative called sodium erythorbate, and allocate customers and territories for a flavor enhancing agent called maltol.” The allegation was made.”
also reports about serious heart valve problemsManufactured by Pfizer’s Shili division, it began to take a toll on the company.
In early 1991, an FDA task force alleged that Shili hid information about safety problems from regulators in order to gain initial approval for his heart valve. On November 7, 1991, a Wall Street Journal investigation found that Shiley had knowingly falsified production records related to the valve fractures. As of 2012, 663 people were reported to have died as a result of these faulty heart valves. Pfizer ultimately agreed to pay damages ranging between $165 million and $215 million.
Deadly drug testing on Nigerian children
In 2000, The Washington Post published a six-part exposé accusing Pfizer of using trovafloxacin (trade name Trovan), a dangerous experimental antibiotic for meningitis. Conducting tests on children in Nigeria without obtaining proper consent from their parents.
When news of a little girl’s death reached the United States, her name was replaced with numbers: #6587-0069. She was 10 years old and weighed just 41 pounds. She lived in Nigeria and suffered from meningitis in April 1996. They gave him 56 mg of Trovan. A day later, the girl’s strength weakened and one of her eyes froze, Pfizer records show.
She died on the third day. Pfizer’s records are clear. Action taken: “Dosage continued unchanged.” Result: “Death.”
A Pfizer company spokesperson said the Trovan experiment was approved by the Nigerian ethics committee and “was justified from a medical, scientific, regulatory and ethical perspective.” According to Wall Street analysts, Trovan should be Pfizer’s next blockbuster drug. One of them claimed: “Pfizer could earn $1 billion per year if Trovan is approved for all possible uses.”
Of the 200 affected children who took part in the experiment, 11 died. Others suffered from meningitis-related symptoms such as deafness, lameness, blindness, seizures, disorientation and, in one case, an inability to walk or talk, company records show. After years of litigation, Pfizer agreed in 2009 to pay $75 million to settle some lawsuits filed in Nigerian courts. Trovan was never approved for use in children in the United States, so production was discontinued. The European Union banned it in 1999.
Fraud through high prices
Below you will find a chronology of other legal controversies involving Pfizer, which we will examine in more detail in the third part of this series:
In 2002, Pfizer agreed to pay $49 million to settle allegations against one of its subsidiaries Defrauded the state’s Medicaid program by overcharging for the cholesterol-lowering drug Lipitor.
Congress enacted the Medicaid rebate program in 1991 to ensure that state Medicaid programs and the federal government do not pay more than the cost of providing drugs to Medicaid beneficiaries. The rebate program is included in the Medicaid waiver agreement that each drug company signs with the federal government in exchange for the privilege of approving their products for use by Medicaid beneficiaries.
Quote: “The Medicaid program was created to ensure that low-income people get medical treatment – And not to enrich pharmaceutical companies or suppliers,” said Robert D. McCallum, Jr., Assistant Attorney General for the Justice Department’s Civil Division. end quote
Following the second part, what do you think about the lack of consent for experiments on African children and Pfizer’s related practices? We already reported on the study in Africa in Season 3 #Episode 9. Has your confidence in the “so-called vaccination” from Biontech/Pfizer increased?
In the third part of this series, we complete the chronology of Pfizer’s “accidents” and turn our attention to a purported “game changer” that may not even stop transmission. Were the approval studies properly conducted?
Do you trust Pfizer?
Links Season 4, Episode 2 (Accessed September 2023)
https://www.justice.gov/archive/atr/public/press_releases/1999/2567.htm
US pharmaceutical giant agrees to pay criminal fine
Participating in two international food additive conspiracies
Pfizer Inc. Agrees to pay criminal fines totaling $20 million. Department of Justice, 19. July 1999
US pharmaceutical giant has agreed to pay a fine for its involvement in two international food additive conspiracies.
Pfizer Inc. agrees to pay fines totaling $20 million
https://www.latimes.com/archives/la-xpm-1991-09-14-fi-2111-story.html
Report says Shili misled FDA on heart valve defects, by Sonny Efron
September 14, 1991, Los Angeles Times
The report said Shiley misled the FDA about heart valve defects and knowingly shipped valves that were manufactured under substandard conditions. “The Shylee convexo-concave heart valve has been defective since its approval,” the FDA report said. “Shiley obtained the sanction by failing to disclose material information he had regarding the defect.”
https://www.ajconline.org/article/S0002-9149(14)00874-1/fulltext
The Björk-Shiley convexo-concave heart valve experience from the perspective of the supervisory panel, Gerard Batts, PhD, Am J Cardiol., March 31, 2014
https://pubmed.ncbi.nlm.nih.gov/24063829/
The Björk-Schiele convex-concave heart valve experience from the perspective of the supervisory panel, Donald C Harrison et al, Am J Cardiol, 2013 December 15
faulty pfizer heart valve
https://www.washingtonpost.com/wp-dyn/content/story/2008/10/01/ST2008100101390.html?sid=ST2008100101390
The Body Hunters, Where Profits and Lives Hang in the Balance, Joe Stephens, Washington Post staff writer, December 17, 2000
Body Hunters where profits and lives are in balance.
Kano, Nigeria – First of six articles When news of the little girl’s death reached the United States, her name was replaced by numbers: number 6587-0069. She was 10 years old and weighed just 41 pounds. She lived in Nigeria and suffered from meningitis in April 1996.
https://www.washingtonpost.com/wp-dyn/content/article/2009/07/30/AR2009073001847.html
Pfizer to pay $75 million to settle Nigerian Trovan drug-testing suit, Joe Stephens, Washington Post staff writer, July 31, 2009
Pfizer to pay $75 million to settle drug testing lawsuit against Trovan in Nigeria
https://www.ema.europa.eu/en/documents/public-statement/public-statement-trovan/trovan-iv/turvel/turvel-iv-withdrawal-marketing-authorisations_en.pdf
Public statement on Trovan/Trovan IV/Turvel/Turvel IV, withdrawal of marketing authorisations, EMA, 21 March 2001
Withdrawal of Trovan marketing authorization by EMA
https://www.justice.gov/archive/opa/pr/2002/October/02_civ_622.htm
Drug giant Pfizer and two subsidiaries must pay $49 million for fraud in the drug Medicaid rebate program, the department. Of Justice, 28. October 2002
Drug company Pfizer and two subsidiaries to pay $49 million for fraudulent Medicaid waiver program
